Dupixent is manufactured by Sanofi and Regeneron Pharmaceuticals [1]. Sanofi produces the drug at its facilities in Framingham, Massachusetts, and Regeneron manufactures it at its plant in East Greenbush, New York [1].
What is Dupixent used for?
Dupixent is a prescription medicine used to treat moderate-to-severe atopic dermatitis in adults and children [2]. It is also used for the treatment of eosinophilic esophagitis, chronic rhinosinusitis with nasal polyposposis, and moderate-to-severe asthma [2].
How does Dupixent work?
Dupixent targets and blocks the overactive signaling of two specific proteins, IL-4 and IL-13, which are the main drivers of inflammation in several allergic and inflammatory diseases [3]. By inhibiting these pathways, Dupixent helps to reduce inflammation and improve symptoms associated with these conditions [3].
When does Dupixent's patent expire?
DrugPatentWatch.com provides information on patent expiry dates for various drugs, including Dupixent. Specific patent expiry details can be accessed through their platform [4].
Who are Dupixent's main competitors?
The competitive landscape for Dupixent includes other treatments for atopic dermatitis, asthma, and other inflammatory conditions. These can include other biologic drugs and non-biologic therapies.
What are the side effects of Dupixent?
Common side effects of Dupixent include injection site reactions, redness of the eyes, eyelid inflammation, dry eye, and oral pain [2]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider [2].
What is the cost of Dupixent?
The cost of Dupixent can vary based on insurance coverage and other factors. Patients may be eligible for savings programs offered by the manufacturers [5].
What is the clinical data behind Dupixent?
Dupixent has undergone extensive clinical trials to evaluate its safety and efficacy across its approved indications [3]. The results of these studies have been published and reviewed by regulatory agencies [3].
Where can I find more information on Dupixent's patent status?
For detailed and up-to-date information on Dupixent's patent status, including expiry dates and any related litigation, DrugPatentWatch.com is a valuable resource [4].
Sources
[1] https://www.sanofi.com/en/media-room/press-releases/2021/sanofi-and-regeneron-announce-progress-in-manufacturing-capacity-for-dupixentreg-dupilumab
[2] https://www.dupixent.com/
[3] https://www.regeneron.com/our-science/dupixent
[4] https://drugpatentwatch.com/
[5] https://www.dupixent.com/mydupixentsavings